Julia Kathleen Rotow, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 9 | 2023 | 5171 | 1.650 |
Why?
|
| Lung Neoplasms | 17 | 2023 | 13019 | 1.490 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2019 | 578 | 1.020 |
Why?
|
| Acrylamides | 1 | 2023 | 252 | 0.820 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2019 | 82 | 0.700 |
Why?
|
| Exons | 2 | 2019 | 2431 | 0.560 |
Why?
|
| Indoles | 1 | 2023 | 1834 | 0.510 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2023 | 5522 | 0.490 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 1525 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2023 | 220 | 0.410 |
Why?
|
| Pyrimidines | 1 | 2023 | 2933 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2023 | 5163 | 0.400 |
Why?
|
| Mutation | 11 | 2023 | 29717 | 0.330 |
Why?
|
| Aniline Compounds | 2 | 2023 | 983 | 0.330 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 2721 | 0.310 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 13655 | 0.270 |
Why?
|
| Factor X | 1 | 2022 | 64 | 0.210 |
Why?
|
| Mastocytosis, Systemic | 1 | 2023 | 100 | 0.200 |
Why?
|
| Immunotherapy | 2 | 2023 | 4414 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2023 | 2455 | 0.200 |
Why?
|
| Vaccines | 1 | 2010 | 817 | 0.200 |
Why?
|
| Mastocytosis | 1 | 2023 | 160 | 0.190 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6347 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2023 | 4553 | 0.160 |
Why?
|
| Carboplatin | 1 | 2019 | 799 | 0.140 |
Why?
|
| Anaphylaxis | 1 | 2023 | 746 | 0.140 |
Why?
|
| Morpholines | 1 | 2019 | 561 | 0.140 |
Why?
|
| Aminopyridines | 1 | 2019 | 541 | 0.130 |
Why?
|
| Remission Induction | 1 | 2018 | 2384 | 0.110 |
Why?
|
| Humans | 20 | 2023 | 742088 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6313 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1581 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6382 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2723 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2028 | 0.080 |
Why?
|
| Genotype | 1 | 2023 | 12946 | 0.080 |
Why?
|
| Genomics | 1 | 2023 | 5692 | 0.080 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 1899 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11039 | 0.070 |
Why?
|
| Phenotype | 1 | 2023 | 16331 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9185 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2018 | 3444 | 0.060 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2023 | 298 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 62966 | 0.050 |
Why?
|
| Animals | 6 | 2023 | 168561 | 0.050 |
Why?
|
| Tryptases | 1 | 2023 | 190 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 2906 | 0.050 |
Why?
|
| Cytidine Deaminase | 1 | 2023 | 251 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 16665 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 81045 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5462 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 2458 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2842 | 0.040 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2018 | 10 | 0.040 |
Why?
|
| Syndecan-4 | 1 | 2018 | 44 | 0.040 |
Why?
|
| Aged | 2 | 2023 | 162944 | 0.040 |
Why?
|
| beta Catenin | 2 | 2017 | 1058 | 0.040 |
Why?
|
| Sialyltransferases | 1 | 2018 | 75 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8621 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 29010 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2018 | 547 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3678 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 677 | 0.040 |
Why?
|
| Male | 3 | 2023 | 349538 | 0.040 |
Why?
|
| Ecosystem | 1 | 2020 | 471 | 0.030 |
Why?
|
| Allergens | 1 | 2023 | 1314 | 0.030 |
Why?
|
| Mast Cells | 1 | 2023 | 1544 | 0.030 |
Why?
|
| Endosomes | 1 | 2018 | 520 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 213127 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 1831 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2023 | 4211 | 0.030 |
Why?
|
| Apoptosis | 2 | 2022 | 9715 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1875 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 670 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 974 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 890 | 0.030 |
Why?
|
| ras Proteins | 1 | 2018 | 1060 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1086 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2715 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9639 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2011 | 0.030 |
Why?
|
| Female | 3 | 2019 | 379592 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4200 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 323 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2010 | 236 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8425 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3564 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 4024 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13029 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6534 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15994 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 721 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5655 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 21596 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5851 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3139 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11001 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10163 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 20774 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13256 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10472 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3504 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5212 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23387 | 0.000 |
Why?
|